Sansure Biotech Inc (688289) — Cash Flow Reinvestment Rate
Sansure Biotech Inc (688289) has a Cash Flow Reinvestment Rate of 1.06x as of September 2025, reinvesting CN¥63.08 Million (capex CN¥63.08 Million ) from operating cash flow of CN¥59.72 Million. See 688289 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Sansure Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see Sansure Biotech Inc (688289) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Sansure Biotech Inc (2018–2025)
Year-by-year capital reinvestment analysis for Sansure Biotech Inc. See financial flexibility index of Sansure Biotech Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.12x | CN¥573.17 Million | CN¥183.96 Million | CN¥369.77 Million | ▲ +7.0% |
| 2024 | 2.91x | CN¥799.38 Million | CN¥274.45 Million | CN¥421.10 Million | ▼ -81.6% |
| 2023 | 15.86x | CN¥1.79 Billion | CN¥112.82 Million | CN¥391.35 Million | ▲ +2251.7% |
| 2022 | 0.67x | CN¥1.73 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -14.8% |
| 2021 | 0.79x | CN¥1.49 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▲ +14.6% |
| 2020 | 0.69x | CN¥1.82 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▼ -88.0% |
| 2019 | 5.75x | CN¥128.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +75.8% |
| 2018 | 3.27x | CN¥32.90 Million | CN¥10.07 Million | CN¥32.90 Million | — |